Roughly one-fourth of patients experience heaviness and pain at least a week before or within a 24-hour window ...
For the quarter ending December 31, 2025, management expects gross revenue of more than US$30.0 million from sales of Ryoncil ® (remestemcel-L-rknd). This represents more than 37% increase on the ...